Delivery Order SPE2DB20D3103-SPE2DB25FQ3M3
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Jardiance 10 mg tablets (90-count packaging). The contract carries a ceiling value of $48,577.98 and employs firm fixed price terms with an ultimate completion date of August 18, 2025. This non-set-aside award was competitively awarded and represents a child delivery order...
- AmerisourceBergen Drug Corp was awarded a competitive delivery order on September 17, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 25 mg, a diabetes medication, with a firm fixed price of $44,282.74 and an ultimate completion date of September 18, 2025. This award represents a child delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $8,158.93 on August 21, 2025, for the supply of Jardiance 25 mg tablets (90 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The company serves as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $17,939.26. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 8, 2025, and will be performed at the company's corporate headquarters in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets (90-count units) with a contract value of $2,009.06. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units. The contract is valued at $8,003.61 and represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025....
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Jardiance 10 mg tablets (90-count packaging) with a ceiling value of $1,131.30. This firm fixed-price delivery order represents a non-competitive award and is set to be completed by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package, with a ceiling value of $3,332.47. This non-set-aside contract utilizes firm fixed price pricing and requires completion by July 22, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency for 30 tablets of Jardiance 10 mg, with a ceiling value of $10,510.63 and an ultimate completion date of September 15, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 10 mg medication. This competitively awarded, non-set-aside contract carries a ceiling value of $36,770.17 and is scheduled for completion by September 11, 2025. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3M3Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $13,445.35. The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a pharmaceutical supply requirement within the federal medical procurement system, specifically supporting military and veteran healthcare needs. This award is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contracting history demonstrates consistent success in competitively awarded pharmaceutical delivery orders across multiple therapeutic domains, positioning the company as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 9/17/25 |